Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 21.33 USD 1.14%
Market Cap: 1.5B USD
Have any thoughts about
Kiniksa Pharmaceuticals Ltd?
Write Note

Solvency Summary

Kiniksa Pharmaceuticals Ltd's solvency score is 79/100. We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and consolidate it into one single number - the solvency score. The higher the solvency score, the more solvent the company is.

79/100
Solvency
Score

We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and consolidate it into one single number - the solvency score. The higher the solvency score, the more solvent the company is.

We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and consolidate it into one single number - the solvency score. The higher the solvency score, the more solvent the company is.

79/100
Solvency
Score
79/100
Solvency
Score

Financial Position

A solvent company is one that owns more than it owes. Comparing the amount of cash and investments with existing debt gives an idea of the company's long-term financial health.

Interest Coverage

To determine how easily a company can pay interest on its outstanding debt, the Interest Coverage ratio is used. It represents how many times the company can pay its obligations using its operating income.

The lower the ratio, the more the company is burdened by debt expenses. When a company's interest coverage ratio is only 1.5 or lower, its ability to meet interest expenses may be questionable.

All Solvency Ratios

Other solvency & liquidity ratios which help to assess the company’s capacity to stay afloat.

See Also

Discover More
Back to Top